Памяти Ирины Ивановны Чукаевой

1. World Health Organization. Global health risks: Mortality and burden of disease attributable to selected major risks. Geneva: World Health Organization, 2009.

2. Lawes C.M, Hoorn S.V, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet 2008; 371 (9623): 1513-8.

3. Chow C.K, Teo K.K, Rangarajan S et al. Prevalence, awareness, treatment, and control of hypertension in rural and urban communities in high-, middle-, and low-income countries. JAMA 2013; 310 (9): 959-68.

4. Nieuwlaat R, Schwalm J.D, Khatib R et al. Why are we failing to implement effective therapies in cardiovascular disease? Eur Heart J 2013; 34 (17): 1262-9.

5. Baker R, Camosso-Stefinovic J, Gillies C et al. Tailored interventions to overcome identified barriers to change: Effects on professional practice and health care outcomes. Cochrane Database Syst Rev 2010; 3.

6. Бойцов С.А., Баланова Ю.А., Шальнова С.А. и др. Артериальная гипертония среди лиц 25-64 лет: распространенность, осведомленность, лечение и контроль. По материалам исследования ЭССЕ. Кардиоваскулярная терапия и профилактика. 2014; 4 (14): 4-14.

7. Максимов С.А., Табакаев М.В., Артамонова Г.В. Интегральная оценка риска ишемической болезни сердца в эпидемиологических исследованиях (ЭССЕ-РФ в Кемеровской области). Сообщение II: социально-экономические детерминанты. Профилактич. медицина. 2016; 1 (19): 24-9.

8. Результаты второго этапа мониторинга эпидемиологической ситуации по артериальной гипертонии в Российской Федерации (2005-2007 гг.), проведенного в рамках федеральной целевой программы «Профилактика и лечение артериальной гипертонии». Информационно-статистич. сб. М., 2008.

9. Mancia G, Fagard R, Narkiewicz K et al. ESH/ESC Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 2013; 31: 1281-357.

10. Wolf-Maier K, Cooper R, Banegas J. Hypertension prevalence and blood pressure levels in 6 European countries, Canada and the United States. JAMA 2003; 289: 2363-9.

11. Шальнова С.А., Баланова Ю.А., Константинов В.В. и др. Артериальная гипертония: распространенность, осведомленность, прием антигипертензивных препаратов и эффективность лечения среди населения Российской Федерации. Рос. кардиологич. журн. 2006; 4: 45-50.

12. Kearney P, Whelton M, Reynolds K et al. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-9.

13. He J, Gu D, Chen J et al. Premature deaths attributable to blood pressure in China. Lancet 2009; 374 (9703): 1765-72.

14. Palafox B, McKee M, Balabanova D et al. Wealth and cardiovascular health: a cross-sectional study of wealth-related inequalities in the awareness, treatment and control of hypertension in high-, middle- and low-income countries. Int J Equity Health 2016; 15 (1): 199.

15. World Bank. How we classify countries. Accessed 2011.

16. Staessen J.A, Wang J.G, Thijs L. Cardiovascular protection and blood pressure reduction: A meta-analysis. Lancet 2001; 358: 1305-15.

17. Ettehad D, Emdin C.A, Kiran A et al. Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis. Lancet 2015; 387 (10 022): 957-67.

18. Chazova I.E, Zhernakova Yu.V, Oshchepkova E.V et al. Prevalence of Cardiovascular Risk Factors in Russian Population of Patients With Arterial Hypertension. Kardiologia 2014; 10: 4-12.

19. Yusuf S, Teo K.K, Pogue J et al. Telmisartan, ramipril, or both in patients at high risk for vascular events. N Engl J Med Massachusetts Med Soc 2008; 358 (15): 1547-59.

20. Heidenreich P.A, Trogdon J.G, Khavjou O.A et al. Forecasting the Future of Cardiovascular Disease in the United States. A Policy Statement From the American Heart Association. Circulation 2011; 123: 933-44.

21. Galdas P.M, Cheater F, Marshall P. Men and health help-seeking behaviour. J Adv Nurs 2005; 49 (6): 616-23.

22. Ostchega Y, Dillon C.F, Hughes J.P et al. Trends in hypertension prevalence, awareness, treatment, and control in older US adults: data from the National Health and Nutrition Examination Survey 1988 to 2004. J Am Geriatr Soc 2007; 55 (7): 1056-65.

23. Gee M.E, Campbell N.R, Gwadry-Sridhar F et al. Antihypertensive medication use, adherence, stops, and starts in Canadians with hypertension. Can J Cardiol 2012; 28 (3): 383-9.

24. Kusuma S.Y. Migrants’ perceptions on barriers to treatment seeking for hypertension: A qualitative study from Delhi, India. Ethnomed 2010; 44 (3): 173-6.

25. Meng X, Dong G, Wang D et al. Prevalence, awareness, treatment, control, and risk factors associated with hypertension in urban adults from 33 communities of China: the CHPSNE study. J Hypertens 2011; 7 (29): 1303-10.

26. Khatib R, Schwalm J-D, Yusuf S et al. Patient and Healthcare Provider Barriers to Hypertension Awareness, Treatment and Follow Up: A Systematic Review and Meta-Analysis of Qualitative and Quantitative Studies. PLoS ONE 2014; 9 (1): e84238.

27. Anthony H, Valinsky L, Inbar Z et al. Perceptions of hypertension treatment among patients with and without diabetes. BMC Fam Pract 2012; 13: 24.

28. Ford C.D, Kim M.J, Dancy B.L et al. Perceptions of hypertension and contributing personal and environmental factors among rural southern African, Аmerican women. Ethn Dis 2009; 19 (4): 407-13.

29. Ogedegbe G, Harrison M, Robbins L et al. Barriers and facilitators of medication adherence in hypertensive African, Аmericans: A qualitative study. Ethn Dis 2004; 14 (1): 3-12.

30. Schafheutle E.I, Hassell K, Noyce P.R et al. Access to medicines: Cost as an influence on the views and behaviour of patients. Health Soc Care Community 2002; 10 (3): 187-95.

31. Parker W.A, Steyn N.P, Levitt N.S et al. Health promotion services for patients having non-comminicable diseases: Feedback from patients and health care providers in cape town, south africa. BMC Public Health 2012; 12: 503.

32. Horowitz C.R, Tuzzio L, Rojas M et al. How do urban African Аmericans and Latinos View the influence of Diet on Hypertension? J Health Care Poor Underserved 2004; 15 (4): 631-44.

33. Wexler R, Elton T, Pleister A et al. Barriers to blood pressure control as reported by African American patients. J Natl Med Assoc 2009; 101 (6): 597-603.

34. Aroian K.J, Peters R.M, Rudner N et al. Hypertension prevention beliefs of hispanics. J Transcult Nurs 2012; 23 (2): 134-42.

35. Greer T.M. Perceived racial discrimination in clinical encounters among African American hypertensive patients. J Health Care Poor Underserved 2010; 21 (1): 251-63.

36. Murimi M.W, Harpel T. Practicing preventive health: The underlying culture among low-income rural populations. J Rural Health 2010; 26 (3): 273-82.

37. Fongwa M.N, Evangelista L.S, Hays R.D et al. Adherence treatment factors in hypertensive Аfrican Аmerican women. Vasc Health Risk Manag 2008; 4 (1): 157-66.

38. Peters D.H, Garg A, Bloom G et al. Poverty and access to health care in developing countries. Ann NY Acad Sci 2008; 1136: 161-71.

39. Barnes D.M, Lu J.H. Mexican immigrants’ and mexican аmericans’ perceptions of hypertension. Qual Health Res 2012; 22 (12): 1685-93.

40. Pham T.M, Rosenthal M.P, Diamond J.J. Hypertension, cardiovascular disease, and health care dilemmas in the philadelphia vietnamese community. Fam Med 1999; 31 (9): 647-51.

41. Arrieta M.I, Foreman R.D, Crook E.D et al. Providing continuity of care for chronic diseases in the aftermath of katrina: From field experience to policy recommendations. Dis Med Pub Health Prep 2009; 3 (3): 174-82.

42. Lim S.S, Vox T, Flaxman A.D et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease. Lancet 2012; 380 (9859): 2224-60.